TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
43
|
36 | |
| Financial expenses |
111
|
701 | |
| Earnings before taxes |
-51
|
-663 | |
| EBITDA |
35
|
28 | |
| Total assets |
1,221
|
1,314 | |
| Current assets |
1,208
|
1,296 | |
| Current liabilities |
85
|
118 | |
| Equity capital |
1,136
|
1,196 | |
| - share capital |
9
|
9 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
93.0%
|
91.0% | |
| Turnover per employee |
43
|
36 | |
| Profit as a percentage of turnover |
-118.6%
|
-1841.7% | |
| Return on assets (ROA) |
4.9%
|
2.9% | |
| Current ratio |
1421.2%
|
1098.3% | |
| Return on equity (ROE) |
-4.5%
|
-55.4% | |
| Change turnover |
8
|
3 | |
| Change turnover % |
-10%
|
21%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.